Algert Global’s Niagen Bioscience NAGE Stock Holding History

Algert Global’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-573,276	Closed	-$3.65M	–	1376
2025 Q4	$3.65M	Buy	573,276 +1,714	+0.3%	+$11.9K	0.06%	544
2025 Q3	$5.33M	Buy	571,562 +446,832	+358%	+$4.51M	0.09%	392
2025 Q2	$1.8M	Buy	124,730 +52,430	+73%	+$518K	0.04%	661
2025 Q1	$499K	Buy	+72,300	New	+$454K	0.01%	916
2022 Q4	–	Sell	-11,770	Closed	-$14K	–	1318
2022 Q3	$14K	Sell	11,770 -28,800	-71%	-$46.3K	﹤0.01%	1153
2022 Q2	$68K	Buy	40,570 +6,490	+19%	+$12.7K	0.01%	1141
2022 Q1	$84K	Buy	+34,080	New	+$93.1K	0.01%	1114
2021 Q3	–	Sell	-12,030	Closed	-$119K	–	1089
2021 Q2	$119K	Buy	+12,030	New	+$105K	0.04%	386
2021 Q1	–	Sell	-27,340	Closed	-$131K	–	548
2020 Q4	$131K	Hold	27,340	–	–	0.04%	366
2020 Q3	$110K	Hold	27,340	–	–	0.03%	355
2020 Q2	$125K	Sell	27,340 -610	-2%	-$2.73K	0.04%	365
2020 Q1	$91K	Buy	+27,950	New	+$107K	0.04%	359

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Algert Global's NAGE Position: Q1 2026 in Review

Algert Global sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 573,276 shares — an estimated $3.65M sold.

Algert Global first reported a position in NAGE in Q1 2020 and held it in 12 quarters. The position peaked at $5.33M in Q3 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

Algert Global reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
Algert Global sold 573,276 Niagen Bioscience shares in Q1 2026, an estimated $3.65M.
Algert Global first reported a position in Niagen Bioscience in Q1 2020 and held it in 12 quarters.
Algert Global's Niagen Bioscience position peaked at $5.33M in Q3 2025.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.